Chronic cough, defined as a cough persisting for eight weeks or longer, presents a significant diagnostic and therapeutic challenge in clinical practice. It not only affects the quality of life of patients but also often eludes precise diagnosis and effective treatment.
Common etiologies of chronic cough include upper airway cough syndrome (UACS), gastroesophageal reflux disease (GERD), and asthma. However, the pathophysiology is multifactorial, involving mechanisms such as heightened cough reflex sensitivity, neurogenic inflammation, and eosinophilic airway inflammation.
An organized, systematic approach is crucial in diagnosing chronic cough. Initial evaluation should include a thorough history and physical examination, focusing on identifying common causes and risk factors. If the initial evaluation is unremarkable, further diagnostic testing such as chest radiography, spirometry, and bronchoprovocation testing may be required.
Treatment should be tailored based on the underlying cause. Empirical treatment trials for UACS, GERD, and asthma may be considered. If no specific cause is identified, symptomatic treatment with cough suppressants and neuromodulators may be beneficial. Refractory cases may require referral to a specialist.
Emerging therapies targeting the neural pathways of cough, such as P2X3 receptor antagonists, have shown promising results in recent clinical trials. These novel therapies may play a significant role in the management of refractory chronic cough in the future.
In conclusion, chronic cough is a complex clinical entity that requires a comprehensive, systematic approach for effective diagnosis and management. Understanding the etiology, pathophysiology, and treatment options is vital for optimal patient care. The advent of novel therapies offers hope for those with refractory chronic cough, signifying a promising future in its management.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation